AzTrials
AzTrials

HealthyNCT05120115

Optimization of Hip-exoskeleton Weight Attributes

A study testing Weight belt in people with Healthy and Gait, Frontal, run by University of Texas at Austin at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators are examining how weight distribution affects the way people walk, in terms of joint kinematics, kinetics, and muscle activity. The investigators are measuring these quantities while people walk while wearing a weighted belt. The investigators distribute the weights and walk for specified periods. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy, Gait, Frontal
What is being tested?
Weight belt
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteUnited States
Study dates
7 Oct 2021to 6 May 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Willing to commit to the full experimental session

Who cannot join

  • Functionally relevant lower limb musculoskeletal injury
  • Functionally relevant osteoarthritis and weight bearing restrictions
  • Severe respiratory problems that restrict the wearer from using a metabolic rate apparatus
  • Patients with cardiac issues may be included, but the cardiac issue will be noted in the health history questionnaire

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Texas at Austin

    Austin, Texas, 78712

Other trials in United States

About this study

Official title: Evaluating Optimal Weight Design Parameters of a Hip Exoskeleton Designed for Rehabilitation.

The investigators are examining how weight distribution affects the way people walk, in terms of joint kinematics, kinetics, and muscle activity. The investigators are measuring these quantities while people walk while wearing a weighted belt. The investigators distribute the weights and walk for specified periods. They hypothesize that greater weight will have a greater effect on walking.

Read the detailed description

The purpose of this study is to examine how the amount and distribution of weight on the pelvis affects how people walk. The investigators two factors, weight and placement. They are examining how these factors affect muscle activation, joint motions and foot forces. The investigators plan to recruit 40 healthy adult individuals. Each of the 20 experimental conditions (3x3 factorial and one control condition with no weight) will be recorded immediately in a single session. The investigators hypothesize that weight amount, gait speed and weight distribution will all affect how people walk, which will lead towards optimized design of hip exoskeletons.

Being tested
Weight belt
Medical subject headings
Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Weight beltOther

    Wearing belt around waist with various weights attached.

Study groups in NCT05120115
Study groupRoleWhat they receive
Weight distribution and placementExperimentalChanging where weight is distributed on belt around pelvis, specifically, bilaterally, 4th lumbar area, unilaterally on the left side. Also changing amount of weight at 0, 4, 6 and 8 kg.
Receives: Other: Weight belt

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pelvic Obliquity

    Amount of pelvic obliquity in response to weighted belt measured using optical motion capture

    Measured: One day

Secondary outcomes (2)
  1. Knee Flexion Angle During Swing Phase

    Knee flexion angle range of motion measured using optical motion capture

    Measured: One Day

  2. Integrated Gastrocnemius Muscle Activity During Preswing Phase of Walking

    EMG signals were normalized via the mean-dynamic method (Burden and Bartlett, 1999), centering the EMG signal around 1. For data analysis, the EMG signal was integrated along each gait phase to calculate the integrated EMG (iEMG) values. For the gastrocnemius, we extrated the iEMG during the pre-swing phase only. The iEMG was normalized to average during walking, resulting in arbitrary units.

    Measured: One day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2021
  2. Study start7 Oct 2021
  3. Primary completion6 May 2022
  4. Study completion6 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05120115
Sponsor's protocol ID
STUDY00001245
Other IDs
R01HD100416
Status last verified
Nov 2023
First submitted
11 Jun 2021
Last updated
29 Nov 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Normand MA, Lee J, Su H, Sulzer JS. The effect of hip exoskeleton weight on kinematics, kinetics, and electromyography during human walking. J Biomech. 2023 May;152:111552. doi: 10.1016/j.jbiomech.2023.111552. Epub 2023 Mar 22.

    PubMed 37004392

Questions about this trial

What is this clinical trial studying?

A study testing Weight belt in people with Healthy and Gait, Frontal, run by University of Texas at Austin at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 29 Nov 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pelvic Obliquity (time frame: One day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05120115, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in